Autopsy report · NCT01100203
Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
Cause of deathSlow enrollment
“It was not possible within the time frame to recruit the planned no. of patients.”
Life of this trial
- Ran for about 1 year 10 months before it stopped.
- 54 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Lene Boesby
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Kidney Disease
- Interventions
- Eplerenone
- Participants
- 54
- Sites
- 2
- Countries
- Denmark
Trials that died the same way
- Non-invasive Improvement of Buttocks With Magnetic Device
“It wasn't possible to recruit the desired number of patients.” - A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell Formulations Targeting CD19 and CD22 in Patients With CD19- and/or CD22-Positive Relapsed/Refractory B-cell Lymphoma
“Suitable patients were not recruited” - A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice
“it was estimated that the recruitment of the planned number of patients could not be completed within further 5 years.” - Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
“No patients recruited.” - Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients
“No patients enrolled. Identification of patients in allocated timeframe was not feasible.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.